Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 3/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | PRKACA | P17612 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | F7 | P08709 | 2/20 | 0.33 |
| ▸ | F3 | P13726 | 2/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 2/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.31 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.31 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14621115 | 1.00 | CDC7 (0.36) | CDC7GSK3BROCK2MAP4K4PRKACA | |
| SCHEMBL4166555 | 0.82 | TGM2 (0.32) | — | |
| SCHEMBL14005022 | 0.78 | CYP1A2 (0.36) | CLK4SMN1; SMN2 | |
| SCHEMBL14608888 | 0.76 | PLK4 (0.38) | GSK3BCDK2GSK3ACDK5 | |
| SCHEMBL4164860 | 0.76 | PLK4 (0.38) | GSK3BCDK2GSK3ACDK5 | |
| SCHEMBL1884372 | 0.74 | GSK3B (0.46) | GSK3BCDK2GSK3ACDK5CDK5R1 | |
| SCHEMBL4164922 | 0.74 | NOTUM (0.31) | GSK3BGSK3A | |
| SCHEMBL1890488 | 0.73 | CYP1A2 (0.39) | GSK3BGSK3ACDK5CDK5R1NPC1 | |
| SCHEMBL4716928 | 0.73 | CYP1A2 (0.34) | CLK4SMN1; SMN2 | |
| SCHEMBL14608695 | 0.71 | TGM2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947679-B2 | Fungicides | SYNGENTA CROP PROTECTION, INC. (US) | 2011-05-24 | — | — | US | disclosed |
| US-7947679-B2 | Fungicides | SYNGENTA CROP PROTECTION, INC. (US) | 2011-05-24 | — | — | US | disclosed |
| US-7947679-B2 | Fungicides | SYNGENTA CROP PROTECTION, INC. (US) | 2011-05-24 | — | — | US | disclosed |
| US-20060069089-A1 | Fungicides | SYNGENTA CROP PROTECTION, INC. | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069089-A1 | Fungicides | CBR3, TACR3, HCRTR1 | CDC7 1109/4885GSK3B 4643/4885ROCK2 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.